What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment
- DOI
- 10.1136/rmdopen-2023-003311
- Published
- 2024-01
- Container
- RMD Open
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2023-003311,
title = {What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment},
author = {Rieke Alten and Juan Carlos Nieto-Gonzalez and Peggy Jacques and Carlomaurizio Montecucco and Robert Moots and Helga Radner and Harald E Vonkeman and Sebastian Heidenreich and Chiara Whichello and Nicolas Krucien and Katrien Van Beneden},
year = {2024},
journal = {RMD Open},
doi = {10.1136/rmdopen-2023-003311},
url = {https://doi.org/10.1136/rmdopen-2023-003311}
}RIS
TY - JOUR TI - What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment AU - Rieke Alten AU - Juan Carlos Nieto-Gonzalez AU - Peggy Jacques AU - Carlomaurizio Montecucco AU - Robert Moots AU - Helga Radner AU - Harald E Vonkeman AU - Sebastian Heidenreich AU - Chiara Whichello AU - Nicolas Krucien AU - Katrien Van Beneden PY - 2024 JO - RMD Open DO - 10.1136/rmdopen-2023-003311 UR - https://doi.org/10.1136/rmdopen-2023-003311 ER -
APA
Alten, R., Nieto-Gonzalez, J. C., Jacques, P., Montecucco, C., Moots, R., Radner, H., Vonkeman, H. E., Heidenreich, S., Whichello, C., Krucien, N., & Beneden, K. V. (2024). What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment. RMD Open. https://doi.org/10.1136/rmdopen-2023-003311
Source records
- crossref · retrieved 2026-09-26T08:03:25.664Z